Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

30 Jun 2020 14:13

RNS Number : 5699R
Allied Minds PLC
30 June 2020
 

30 June 2020

 

Allied Minds

 

Results of Annual General Meeting

 

The Annual General Meeting of Allied Minds plc was held earlier today. All of the resolutions proposed at the Annual General Meeting were duly passed by the shareholders on a poll.

 

The results of the poll, incorporating the proxy votes lodged in advance of the meeting, are set out below.

 

Resolutions

For

%

Against

%

Withheld

Total lodged

1. To receive the Company's Annual Report and Accounts for the year ended 31 December 2019.

165,894,649

 

99.97

 

55,570

 

0.03

 

1,052,648

 

165,950,219

 

2. To approve the Directors' Remuneration Report for the year ended 31 December 2019.

104,798,226

 

62.75

 

62,200,421

 

37.25

 

4,220

 

166,998,647

 

3. To re-appoint KPMG LLP as auditor of the Company.

165,910,195

 

99.98

 

36,425

 

0.02

 

1,056,248

 

165,946,620

 

4. To authorise the Audit Committee to determine the auditor's remuneration.

166,966,426

 

99.98

 

33,425

 

0.02

 

3,017

 

166,999,851

 

5. To re-elect Mr. Harry Rein as a Director of the Company.

159,208,292

 

95.94

 

6,733,805

 

4.06

 

1,060,770

 

165,942,097

 

6. To re-elect Mr. Joseph Pignato as a Director of the Company.

166,863,283

 

99.92

 

131,446

 

0.08

 

8,139

 

166,994,729

 

7. To elect Mr. Mark Lerdal as a Director of the Company.

166,962,826

99.98

31,903

0.02

8,139

166,994,729

8. To elect Mr. Bruce Failing as a Director of the Company.

166,863,283

99.92

131,446

0.08

8,139

166,994,729

9. To authorise the Directors to allot shares under section 551 of the Companies Act 2006.

159,117,727

95.28

7,881,524

4.72

3,617

166,999,251

10. To disapply statutory pre-emption rights.

159,138,624

 

95.29

 

7,860,627

 

4.71

 

3,617

 

166,999,251

 

11. In addition to the authority granted under Resolution 10, to disapply statutory pre-emption rights solely in relation to acquisitions and specified capital investments.

 

158,061,868

 

94.65

 

8,937,382

 

5.35

 

3,617

 

166,999,250

12. To authorise the Company to make political donations and incur political expenditure.

166,858,746

 

99.91

 

142,618

 

0.09

 

1,504

 

167,001,364

 

13. To authorise the Company to make market purchases of its own shares.

165,895,719

 

99.34

 

1,107,131

 

0.66

 

17

 

167,002,850

 

14. To authorise the Company to hold general meetings on not less than 14 clear days' notice.

166,490,893

 

99.69

 

511,958

 

0.31

 

17

 

167,002,851

 

While all resolutions were passed at the annual general meeting, we were disappointed that there was a significant minority of votes against the advisory resolution on the Remuneration Report. Overall, the Remuneration Committee considers that the remuneration structure continues to be broadly appropriate and aligned with the Company's strategy while balancing typical UK-listed market practice with US practice in our market for talent. Furthermore, we believe that the amendments we made to the Company's remuneration programme for 2020 and onwards after receiving extensive shareholder feedback have appropriately addressed shareholder concerns. Nevertheless, in line with our commitment to maintaining an open and transparent dialogue with shareholders, we will be consulting with major shareholders in the second half of 2020 to gain their input in this review. We will also consult further on the concerns raised on this resolution and in accordance with the UK Corporate Governance Code, we will publish an update on that engagement within six months of the AGM.

 

Notes:

 

1. A vote "Withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

2. As at 30 June 2020, the number of issued shares in the Company was 242,118,107 ordinary shares, which was the total number of shares entitling the holders to attend and vote for or against all the resolutions at the AGM. In accordance with the Company's Articles of Association, on a poll every member present in person or by proxy has one vote for every share held.

 

3. The full text of the resolutions may be found in the Notice of the Annual General Meeting, copies of which are available on both the Company's website www.alliedminds.com and on the National Storage Mechanism.

 

4. In accordance with Listing Rule 9.6.1, a copy of the resolutions, other than those concerning ordinary business has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.

About Allied Minds

 

Allied Minds plc is an IP commercialisation company focused on early stage company development within the technology sector. With origination relationships that span US federal laboratories, universities, and leading US corporations, Allied Minds historically created, and now operates and funds, a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, Allied Minds supports its businesses with capital, management, expertise and shared services. For more information, please visit www.alliedminds.com.

 

For more information, please contact:

 

Allied Minds plc

c/o Instinctif Partners

Joseph Pignato

Instinctif Partners

AlliedMinds@instinctif.com

Adrian Duffield / Kay Larsen / Chantal Woolcock

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGXBLFXBQLFBBB
Date   Source Headline
31st Jan 20173:55 pmRNSTotal Voting Rights
30th Jan 201712:02 pmRNSPrice Monitoring Extension
3rd Jan 20172:48 pmRNSHolding(s) in Company
3rd Jan 20172:11 pmRNSTotal Voting Rights
13th Dec 20167:00 amRNSFormation of Signature Medical, Inc.
9th Dec 20165:04 pmRNSHolding(s) in Company
7th Dec 20164:34 pmRNSHolding(s) in Company
6th Dec 20165:05 pmRNSHolding(s) in Company
6th Dec 20165:04 pmRNSHolding(s) in Company
2nd Dec 20167:00 amRNSResults of equity placing
1st Dec 20164:50 pmRNSProposed Equity Placing
23rd Nov 20167:00 amRNSHawkEye 360 Raises $11m in Series A Financing
21st Nov 20167:00 amRNSFormation of Vatic Materials, Inc.
18th Nov 20163:15 pmRNSBlock Listing Six Monthly Return
11th Nov 20165:17 pmRNSHolding(s) in Company
24th Oct 20167:00 amRNSPrecision Biopsy Raises $5.0 Million
17th Oct 201612:07 pmRNSSecond Price Monitoring Extn
17th Oct 201612:02 pmRNSPrice Monitoring Extension
29th Sep 20167:00 amRNSAllied Minds & GE Ventures Form Strategic Alliance
8th Sep 201612:02 pmRNSPrice Monitoring Extension
31st Aug 20165:11 pmRNSTotal Voting Rights
25th Aug 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSAllied Minds Secures $20m Debt Facility from SVB
22nd Aug 20167:00 amRNSAllied Minds' Subsidiary ABLS II Raises $15m
1st Aug 20167:00 amRNSSciFluor Enters Clinical Trial Stage
29th Jul 201610:30 amRNSTotal Voting Rights
13th Jul 201610:02 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:00 amRNSDirector/PDMR Shareholding
7th Jul 20167:00 amRNSLong Term Incentive Plan - Listing Application
30th Jun 20167:00 amRNSTotal Voting Rights
22nd Jun 20164:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20164:35 pmRNSPrice Monitoring Extension
14th Jun 20162:38 pmRNSDirector/PDMR Shareholding
13th Jun 20165:18 pmRNSDirector/PDMR Shareholding
31st May 20164:44 pmRNSBlocklisting Six Monthly Return
26th May 20165:23 pmRNSResult of AGM
26th May 20167:00 amRNSAGM Statement
25th May 20167:00 amRNSABLS II Completes Drug Feasibility Programme
13th May 20167:00 amRNSDirector/PDMR Shareholding
10th May 20164:30 pmRNSLong Term Incentive Plan
28th Apr 201612:33 pmRNSHolding(s) in Company
26th Apr 20167:00 amRNSAllied Minds Raises $80m for ABLS Capital
25th Apr 20167:00 amRNSAnnual Financial Report
19th Apr 20167:00 amRNSAppointment of Joint Broker
16th Mar 20167:00 amRNSABLS agrees license with NYU
10th Feb 20164:40 pmRNSSecond Price Monitoring Extn
10th Feb 20164:36 pmRNSPrice Monitoring Extension
9th Feb 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.